274
Participants
Start Date
October 31, 2007
Primary Completion Date
January 31, 2010
Study Completion Date
July 31, 2010
Botulinum Toxin Type A 900kD
"The exact dosage and number of injection sites is based on the size, number, and location of muscles involved; the severity of spasticity; and the presence of local muscle weakness.~First intra-muscular injection at the Baseline visit, and optional second injection of the randomised treatment after a minimum of 12 weeks to a maximum of 24 weeks following the Baseline visit."
Placebo
"The exact dosage and number of injection sites is based on the size, number, and location of muscles involved; the severity of spasticity; and the presence of local muscle weakness.~First intra-muscular injection at the Baseline visit, and optional second injection of the randomised treatment after a minimum of 12 weeks to a maximum of 24 weeks following the Baseline visit."
Edmonton
Beelitz
Uppsala
Burslem
Lead Sponsor
Allergan
INDUSTRY